Prevention of heart disease and healthcare delivery in South Africa: Challenges and opportunities

Africa is a vast and diverse continent, and this is reflected in multiple facets of healthcare prevention and delivery. Africa also shares with many other lower- and middle-income countries (LMIC) the spectre of a global epidemic of cardiovascular disease in juxtaposition with a considerable burden of communicable diseases.(1) This supplement of the South African Heart Association Journal is centred around the Southern African region, but it addresses a wide range of timely issues of relevance not only to other regions of the continent but in the context of LMIC and newly industrialised nations around the world. The concept of the “epidemiologic transition” provides a very useful framework for understanding epidemiological trends in cardiovascular disease against a backdrop of profound changes in many societies evolving from a rural to an urban environment and in the face of challenges posed by the newly industrialised societies

Approach to device-detected subclinical atrial fibrillation

Subclinical atrial fibrillation, a commonly encountered entity in patients with implantable devices, has been associated with a number of adverse outcomes – the most important of which is thromboembolism. Through the detection of atrial high rate episodes, implanted devices offer a method to monitor for atrial fibrillation over extended periods of time. Several studies have demonstrated that patients with device-detected atrial tachyarrhythmias have an increased incidence of stroke, especially in the presence of additional risk factors. Yet, there are many uncertainties with limited evidence from randomised clinical studies and no formal guidelines to inform management in this population. This contributes to marked practice heterogeneity, underrecognition and missed opportunities for stroke prevention. We propose a logical approach to management of patients with device-detected atrial high rate episodes pending additional data from ongoing trials

Impact of socioeconomic status, ethnicity, and urbanization on risk factor profiles of cardiovascular disease in Africa

Africa is a continent characterized by marked ethnic, sociodemographic, and economic diversity, with profound changes in many regions over the past 2 decades. This diversity has an impact on cardiovascular disease presentation and outcomes. Within Africa and within the individual countries, one can find regions having predominantly communicable diseases such as rheumatic heart disease, tuberculous pericarditis, or cardiomyopathy and others having a marked increase in noncommunicable disease such as hypertension and hypertensive heart disease. Ischemic heart disease remains rare in most countries. Difficulties in the planning and implementation of effective health care in most African countries are compounded by a paucity of studies and a low rate of investment in research and data acquisition. The fiduciary responsibilities of companies working in Africa should include the effective and efficient use of natural resources to promote the overall health of populations

Bill Piller

N/

To stent or not to stent? Treating angina after ISCHEMIA—introduction

n/

Referral for coronary artery revascularization procedures after diagnostic coronary angiography: Evidence for gender bias?

AbstractObjectives. We sought to determine whether there is a gender bias in the selection of patients for coronary revascularization once the severity of the underlying coronary artery disease has been established with angiography.Background. It has been suggested that women with coronary artery disease are less likely to be referred for coronary angiography and coronary artery bypass surgery than men. Whether such a referral bias for revascularization procedures, including coronary angioplasty, is present once angiography has been performed is not clear.Methods. We retrospectively analyzed 22,795 patients with suspected coronary artery disease who underwent coronary angiography between 1981 and 1991 and compared the numbers of women and men who underwent either coronary artery bypass surgery or coronary angioplasty within 30 days of coronary angiography.Results. Angiography revealed significant (one-vessel or more) disease in 15,455 patients (52% of women, 76% of men). Despite worse symptoms, women had less extensive coronary disease than men as judged by the number of vessels diseased. Women were also more likely to have other co-morbid diseases. An equal proportion of women (54%) and men underwent revascularization procedures. After adjustment for baseline differences and age, differences in the two individual revascularization strategies were very small: More women tended to have coronary angioplasty ([absolute difference ± 1 SD] + 3.3 ± 0.7%, p < 0.0001), but fewer had coronary artery bypass surgery than men (−2.5 ± 0.8%, p = 0.003). When the two revascularization strategies were considered together, there was no significant gender difference in overall adjusted use of revascularization (+0.8 ± 0.9%, p = 0.41).Conclusions. Once diagnostic coronary angiography had been performed, no major differences in the overall utilization of revascularization procedures were noted for women compared with men

Outcome of Patients With Hypertrophic Cardiomyopathy and a Normal Electrocardiogram

ObjectivesThis study sought to clarify the frequency, clinical phenotype, and prognosis of those patients with hypertrophic cardiomyopathy (HCM) who present with a normal electrocardiogram (ECG).BackgroundHypertrophic cardiomyopathy is the most common cause of sudden death in young people. Screening advocates have recommended a 12-lead ECG for the early detection of HCM in athletes, yet the clinical outcomes of those presenting with a normal ECG remains to be fully delineated.MethodsBaseline characteristic and echocardiographic data were collected on all patients with HCM who initially presented to our institution with a diagnostic echocardiogram but a normal ECG. Follow-up was obtained and compared with the prognosis of HCM patients who presented with abnormal ECGs.ResultsWe compared 135 HCM patients with a normal ECG with 2,350 HCM patients with an abnormal ECG. The latter group was more likely to have worse symptoms, have higher gradients, and a greater degree of septal wall thickness than the patients with a normal ECG. Severe obstructive symptoms requiring surgical myectomy and implantation of an implantable cardioverter-defibrillator were more common in patients with abnormal ECGs. Cardiac survival was significantly better in the group with a normal ECG at presentation—none of these patients had a cardiac death at follow-up.ConclusionsAlmost 6% of patients presenting with demonstrable echocardiographic evidence of HCM had a normal ECG at the time of diagnosis. This subset of patients with normal ECG-HCM appears to exhibit a less severe phenotype with better cardiovascular outcomes